Bai Hua, Feng Xiao-Feng
Department of Neurology, The Third Affiliated Hospital of Guizhou Medical University, Duyun 558099, Guizhou Province, China.
Department of Neurology, Wulong Branch of the People's Hospital Affiliated to Chongqing University, Wulong 408500, Chongqing, China.
World J Clin Cases. 2025 Jan 6;13(1):100833. doi: 10.12998/wjcc.v13.i1.100833.
Dementia is a group of diseases, including Alzheimer's disease (AD), vascular dementia, Lewy body dementia, frontotemporal dementia, Parkinson's disease dementia, metabolic dementia and toxic dementia. The treatment of dementia mainly includes symptomatic treatment by controlling the primary disease and accompanying symptoms, nutritional support therapy for repairing nerve cells, psychological auxiliary treatment, and treatment that improves cognitive function through drugs. Among them, drug therapy to improve cognitive function is important. This review focuses on introducing and commenting on some recent progress in exploring drugs to improve cognitive function, especially the new progress in drug treatment for AD. We mainly discuss the opportunities and challenges in finding and developing new therapeutic drugs from the aspects of acetylcholinesterase, N-methyl-D-aspartate glutamate receptor, amyloid protein, tau protein and chronic immune inflammation.
痴呆症是一组疾病,包括阿尔茨海默病(AD)、血管性痴呆、路易体痴呆、额颞叶痴呆、帕金森病痴呆、代谢性痴呆和中毒性痴呆。痴呆症的治疗主要包括通过控制原发性疾病和伴随症状进行对症治疗、修复神经细胞的营养支持疗法、心理辅助治疗以及通过药物改善认知功能的治疗。其中,改善认知功能的药物治疗很重要。本综述重点介绍和评述在探索改善认知功能药物方面的一些最新进展,尤其是AD药物治疗的新进展。我们主要从乙酰胆碱酯酶、N-甲基-D-天冬氨酸谷氨酸受体、淀粉样蛋白、tau蛋白和慢性免疫炎症等方面讨论寻找和开发新治疗药物的机遇与挑战。